Immunology and Microbiology
COVID-19
100%
Immunogenicity
65%
Immune Response
55%
Severe Acute Respiratory Syndrome Coronavirus 2
50%
Primary Immunodeficiency
43%
Neutralizing Antibody
43%
Common Variable Immunodeficiency
34%
T Cell
34%
Omicron Coronavirus Variant
32%
Dengue Fever
27%
Virus
26%
Viral Disease
25%
Hepatitis B Vaccination
21%
Hepatitis A
21%
Hepatitis Virus
21%
Monkeypox Virus
21%
Vaccinium
21%
Smallpox Vaccine
21%
Orthopoxvirus
21%
Antibody-Dependent Enhancement
21%
Glycosylation
21%
Antigen Specificity
21%
Immunoglobulin G1
21%
Hematopoietic Stem Cell Transplantation
21%
Hepatitis B Virus
21%
Spike
17%
Enterobacterales
16%
Neutralization
16%
Binding Antibody
15%
Antibody Response
14%
Humoral Immune Deficiency
14%
Immunoglobulin G
14%
Allogeneic Hematopoietic Stem Cell Transplantation
14%
Autologous Hematopoietic Stem Cell Transplantation
12%
Phagocyte
12%
Antibody Titer
11%
Lineages
10%
Monkeypox
10%
Breakthrough Infection
9%
Immunodeficiency
9%
B Cell
9%
X-Linked Agammaglobulinemia
8%
Immunosuppressive Drug
7%
Humoral Immunity
7%
Adoptive Immunity
7%
Vaccine Efficacy
7%
Smallpox
7%
Glycopeptide
7%
Liquid Chromatography Mass Spectrometry
7%
Yellow Fever
6%
Medicine and Dentistry
Infection
44%
Messenger RNA
43%
Severe Acute Respiratory Syndrome Coronavirus 2
26%
Dengue Fever
24%
COVID-19
22%
Virus
22%
Medical Student
21%
Health Care
21%
Randomized Controlled Trial
21%
Omicron Coronavirus Variant
21%
Hepatitis B Vaccination
21%
Immunogenicity
21%
Hepatitis B Virus
21%
Hepatitis Virus
21%
Hepatitis A
21%
Cohort Effect
21%
Antibody Dependent Enhancement
21%
Antiviral Drug
21%
Cohort Study
21%
Immune Response
21%
Bacterial Infection
21%
Emergency Department
21%
Virus Infection
21%
Hematopoietic Stem Cell Transplantation
21%
Bloodstream Infection
21%
Carbapenem
13%
Outpatient
10%
Chronic Lung Disease
10%
Diseases
10%
Allogeneic Hematopoietic Stem Cell Transplantation
10%
Autologous Hematopoietic Stem Cell Transplantation
8%
COVID-19 Vaccination
6%
Yellow Fever
6%
Immunosuppressive Treatment
5%
Reinfection
5%
Monoclonal Antibody
5%
Pre-Existing Condition
5%
Cardiovascular System
5%
Reverse Transcription Polymerase Chain Reaction
5%
Prevalence
5%
Comorbidity
5%
Pharmacology, Toxicology and Pharmaceutical Science
Messenger RNA
43%
Infection
41%
Dengue
32%
SARS Coronavirus
26%
Immunogenicity
21%
Randomized Controlled Trial
21%
Antibody Dependent Enhancement
21%
Cohort Study
21%
Virus Infection
21%
Bacterial Infection
21%
Virus Hepatitis
21%
Hepatitis B Virus
21%
Hepatitis B
21%
Hepatitis A
21%
Diseases
19%
Antiviral Drug
17%
Yellow Fever
10%
Chronic Lung Disease
8%
Immunoglobulin G
6%
Arthropod
5%
Lassa Fever
5%
Flavivirus
5%
Immunoglobulin M
5%
Rift Valley Fever
5%
Hemorrhagic Fever
5%
Hantavirus
5%
Necrosis
5%
Epstein-Barr Virus
5%
Hepatitis A Virus
5%
Mortality Rate
5%
Flu Like Syndrome
5%
Crimean Congo Hemorrhagic Fever
5%
Cytomegalovirus
5%